Quantum BioPharma plans to issue special dividends in the form of Contingent Value Rights to align shareholder interests with potential legal outcomes. Tonix Pharmaceuticals appoints James Hunter to its Board of Directors in preparation for a potential product launch, while BioUtah showcases Utah's thriving life sciences sector at the BIO International Convention.
